Given its involvement in cardiac hypertrophy, ischemia, autophagy, and cardiomyopathy, mTOR represents a critical target for potential therapeutic interventions aimed at treating or preventing heart disease. This evidence concerns the gene MTOR and cardiac hypertrophy.